FDA — authorised 23 March 2022
- Marketing authorisation holder: AAA USA NOVARTIS
- Status: approved
🇺🇸 Pluvicto in United States
FDA authorised Pluvicto on 23 March 2022
Marketing authorisation
Pluvicto in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Pluvicto approved in United States?
Yes. FDA authorised it on 23 March 2022.
Who is the marketing authorisation holder for Pluvicto in United States?
AAA USA NOVARTIS holds the US marketing authorisation.